Literature DB >> 10577940

Founder BRCA1/2 mutations among male patients with breast cancer in Israel.

J P Struewing, Z M Coriaty, E Ron, A Livoff, M Konichezky, P Cohen, M B Resnick, B Lifzchiz-Mercerl, S Lew, J Iscovich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10577940      PMCID： PMC1288396          DOI： 10.1086/302678

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  11 in total

1.  Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.

Authors:  S L Neuhausen; A K Godwin; R Gershoni-Baruch; E Schubert; J Garber; D Stoppa-Lyonnet; E Olah; B Csokay; O Serova; F Lalloo; A Osorio; M Stratton; K Offit; J Boyd; M A Caligo; R J Scott; A Schofield; E Teugels; M Schwab; L Cannon-Albright; T Bishop; D Easton; J Benitez; M C King; B A Ponder; B Weber; P Devilee; A Borg; S A Narod; D Goldgar
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

2.  The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim.

Authors:  R B Bar-Sade; A Kruglikova; B Modan; E Gak; G Hirsh-Yechezkel; L Theodor; I Novikov; R Gershoni-Baruch; S Risel; M Z Papa; G Ben-Baruch; E Friedman
Journal:  Hum Mol Genet       Date:  1998-05       Impact factor: 6.150

3.  Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population.

Authors:  L S Friedman; S A Gayther; T Kurosaki; D Gordon; B Noble; G Casey; B A Ponder; H Anton-Culver
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

4.  The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.

Authors:  J P Struewing; P Hartge; S Wacholder; S M Baker; M Berlin; M McAdams; M M Timmerman; L C Brody; M A Tucker
Journal:  N Engl J Med       Date:  1997-05-15       Impact factor: 91.245

5.  Identification of the breast cancer susceptibility gene BRCA2.

Authors:  R Wooster; G Bignell; J Lancaster; S Swift; S Seal; J Mangion; N Collins; S Gregory; C Gumbs; G Micklem
Journal:  Nature       Date:  1995 Dec 21-28       Impact factor: 49.962

6.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; M Stratton; S Narod; D Goldgar; P Devilee; D T Bishop; B Weber; G Lenoir; J Chang-Claude; H Sobol; M D Teare; J Struewing; A Arason; S Scherneck; J Peto; T R Rebbeck; P Tonin; S Neuhausen; R Barkardottir; J Eyfjord; H Lynch; B A Ponder; S A Gayther; M Zelada-Hedman
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

7.  BRCA2 germline mutations in male breast cancer cases and breast cancer families.

Authors:  F J Couch; L M Farid; M L DeShano; S V Tavtigian; K Calzone; L Campeau; Y Peng; B Bogden; Q Chen; S Neuhausen; D Shattuck-Eidens; A K Godwin; M Daly; D M Radford; S Sedlacek; J Rommens; J Simard; J Garber; S Merajver; B L Weber
Journal:  Nat Genet       Date:  1996-05       Impact factor: 38.330

8.  A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes.

Authors:  S Thorlacius; G Olafsdottir; L Tryggvadottir; S Neuhausen; J G Jonasson; S V Tavtigian; H Tulinius; H M Ogmundsdottir; J E Eyfjörd
Journal:  Nat Genet       Date:  1996-05       Impact factor: 38.330

9.  High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history.

Authors:  B Csokay; N Udvarhelyi; Z Sulyok; I Besznyak; S Ramus; B Ponder; E Olah
Journal:  Cancer Res       Date:  1999-03-01       Impact factor: 12.701

10.  BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease.

Authors:  K Haraldsson; N Loman; Q X Zhang; O Johannsson; H Olsson; A Borg
Journal:  Cancer Res       Date:  1998-04-01       Impact factor: 12.701
View more
  14 in total

1.  Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States.

Authors:  Yuan Chun Ding; Linda Steele; Chih-Jen Kuan; Scott Greilac; Susan L Neuhausen
Journal:  Breast Cancer Res Treat       Date:  2010-10-07       Impact factor: 4.872

Review 2.  The Epidemiology of Male Breast Cancer.

Authors:  Raina M Ferzoco; Kathryn J Ruddy
Journal:  Curr Oncol Rep       Date:  2016-01       Impact factor: 5.075

Review 3.  Hereditary breast cancer in Jews.

Authors:  Wendy S Rubinstein
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

4.  Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence from 261 cases in Israel, 1976-1999.

Authors:  Gabriel Chodick; Jeffery P Struewing; Elaine Ron; Joni L Rutter; Jose Iscovich
Journal:  Eur J Med Genet       Date:  2007-11-22       Impact factor: 2.708

5.  How old is this mutation? - a study of three Ashkenazi Jewish founder mutations.

Authors:  Celia M T Greenwood; Shuying Sun; Justin Veenstra; Nancy Hamel; Bethany Niell; Stephen Gruber; William D Foulkes
Journal:  BMC Genet       Date:  2010-05-14       Impact factor: 2.797

Review 6.  Genetic counseling and testing for common hereditary breast cancer syndromes: a paper from the 2007 William Beaumont hospital symposium on molecular pathology.

Authors:  Dawn C Allain
Journal:  J Mol Diagn       Date:  2008-08-07       Impact factor: 5.568

7.  Breast cancer risk among male BRCA1 and BRCA2 mutation carriers.

Authors:  Yu Chuan Tai; Susan Domchek; Giovanni Parmigiani; Sining Chen
Journal:  J Natl Cancer Inst       Date:  2007-11-27       Impact factor: 13.506

Review 8.  Second cancers in patients with male breast cancer: a literature review.

Authors:  Tal Grenader; Anthony Goldberg; Linda Shavit
Journal:  J Cancer Surviv       Date:  2008-04-01       Impact factor: 4.442

9.  BRCA2 mutations in 154 finnish male breast cancer patients.

Authors:  Kirsi Syrjäkoski; Tuula Kuukasjärvi; Kati Waltering; Karin Haraldsson; Anssi Auvinen; Ake Borg; Tommi Kainu; Olli-P Kallioniemi; Pasi A Koivisto
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

10.  Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.

Authors:  Kate M Im; Tomas Kirchhoff; Xianshu Wang; Todd Green; Clement Y Chow; Joseph Vijai; Joshua Korn; Mia M Gaudet; Zachary Fredericksen; V Shane Pankratz; Candace Guiducci; Andrew Crenshaw; Lesley McGuffog; Christiana Kartsonaki; Jonathan Morrison; Sue Healey; Olga M Sinilnikova; Phuong L Mai; Mark H Greene; Marion Piedmonte; Wendy S Rubinstein; Frans B Hogervorst; Matti A Rookus; J Margriet Collée; Nicoline Hoogerbrugge; Christi J van Asperen; Hanne E J Meijers-Heijboer; Cees E Van Roozendaal; Trinidad Caldes; Pedro Perez-Segura; Anna Jakubowska; Jan Lubinski; Tomasz Huzarski; Paweł Blecharz; Heli Nevanlinna; Kristiina Aittomäki; Conxi Lazaro; Ignacio Blanco; Rosa B Barkardottir; Marco Montagna; Emma D'Andrea; Peter Devilee; Olufunmilayo I Olopade; Susan L Neuhausen; Bernard Peissel; Bernardo Bonanni; Paolo Peterlongo; Christian F Singer; Gad Rennert; Flavio Lejbkowicz; Irene L Andrulis; Gord Glendon; Hilmi Ozcelik; Amanda Ewart Toland; Maria Adelaide Caligo; Mary S Beattie; Salina Chan; Susan M Domchek; Katherine L Nathanson; Timothy R Rebbeck; Catherine Phelan; Steven Narod; Esther M John; John L Hopper; Saundra S Buys; Mary B Daly; Melissa C Southey; Mary-Beth Terry; Nadine Tung; Thomas V O Hansen; Ana Osorio; Javier Benitez; Mercedes Durán; Jeffrey N Weitzel; Judy Garber; Ute Hamann; Susan Peock; Margaret Cook; Clare T Oliver; Debra Frost; Radka Platte; D Gareth Evans; Ros Eeles; Louise Izatt; Joan Paterson; Carole Brewer; Shirley Hodgson; Patrick J Morrison; Mary Porteous; Lisa Walker; Mark T Rogers; Lucy E Side; Andrew K Godwin; Rita K Schmutzler; Barbara Wappenschmidt; Yael Laitman; Alfons Meindl; Helmut Deissler; Raymonda Varon-Mateeva; Sabine Preisler-Adams; Karin Kast; Laurence Venat-Bouvet; Dominique Stoppa-Lyonnet; Georgia Chenevix-Trench; Douglas F Easton; Robert J Klein; Mark J Daly; Eitan Friedman; Michael Dean; Andrew G Clark; David M Altshuler; Antonis C Antoniou; Fergus J Couch; Kenneth Offit; Bert Gold
Journal:  Hum Genet       Date:  2011-05-20       Impact factor: 4.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.